heparin mechanism of action uses clinical pharmacology
Reading File
Generating Image
Here is your heparin diagram:
Here's a summary of what the diagram covers, drawn from Braunwald's Heart Disease and clinical pharmacology sources:
What is Heparin?
Heparin is a sulfated polysaccharide anticoagulant derived from porcine intestinal mucosa. It is one of the oldest and most widely used anticoagulants in medicine.
Mechanism of Action
Heparin binds to Antithrombin (AT-III) via a unique pentasaccharide sequence, causing a conformational change that dramatically accelerates AT-III's inhibition of:
Thrombin (Factor IIa) - requires the heparin chain to bridge AT and thrombin together (needs chains ≥18 saccharide units)
Factor Xa - inhibited by the conformational change alone
It also releases Tissue Factor Pathway Inhibitor (TFPI) from the endothelium.
Types
Type
MW
Anti-Xa:Anti-IIa
Monitor
UFH
5,000-30,000 Da
1:1
aPTT
LMWH (e.g. enoxaparin)
~5,000 Da
~3:1
Anti-Xa
Fondaparinux
1,500 Da
Xa only
Anti-Xa
Key Clinical Uses
DVT/PE treatment and prophylaxis
Acute coronary syndromes (NSTEMI/STEMI)
Atrial fibrillation
Cardiac surgery / cardiopulmonary bypass
Dialysis and CRRT
Peri-procedural bridging anticoagulation
Pregnancy (LMWH is preferred)
Major Adverse Effects
Bleeding (most common)
HIT (Heparin-Induced Thrombocytopenia) - ~5% with UFH, immune-mediated, occurs days 5-14